Our Business
Logistics System
Our mission is to ensure delivery of pharmaceuticals.
Prescription pharmaceuticals are directly linked to lives and health of patients.
For fulfilling our mission to distribute secure and safe pharmaceuticals, we achieve the highest level of quality (thorough quality control), safety (traceability) and efficiency (establishment of the efficient logistics environment) by introducing cutting-edge technologies.
Seeking for the Ultimate Accuracy
In order to deliver pharmaceuticals in a secure and safe manner, we are aiming at full automation of the logistics system by utilizing the advanced robot technology. Our latest logistics center has introduced robots for picking and loading, resulting in higher efficiency with less workload. Our shipment accuracy is 99.99999%. Moreover, our guaranteed shipping accuracy allows for the omission of inspections at delivery to our clients. This enables to greatly reduce the inspection time for clients.
Robust Business Infrastructures
You can swipe to view
The Group’s business infrastructure is constantly linking core systems managing sales, inventory, etc., with information systems managing sales operation, customers, etc., for automated data processing. We have also been focusing on the traceability for many years, and have established a system that enables centralized management of necessary information at sales offices and logistics centers nationwide.
Pharmaceutical Supply at the Time of Disaster
We cannot halt pharmaceutical supply even at the time of an unpredictable disaster. In anticipation of a disaster, we have established the structure for stable supply of pharmaceuticals in an emergency by redundant host computer and warehouse management system, coordination among call centers, installation of uninterruptible devices and periodic emergency drill.
We are also operating a highly-functional, consolidated, large logistics center “TBC DynaBASE” inside Keihin Truck Terminal, which is the wide-area transportation base designated by the Tokyo Metropolitan Government in an attempt to supply pharmaceuticals immediately and smoothly even in the event of a large-scale disaster.
Initiatives for Specialty Pharmaceuticals
Specialty products, including biomedical products such as orphan drugs and regenerative medical products, require strict temperature control and other measures, making it essential to establish an optimal logistics system tailored to the specific needs of each product. The Group has established an advanced logistics and temperature control system to ensure a stable and continuous supply.
1. Full-Line Service for Specialty Products
You can swipe to view
The Group is promoting a Full-Line Service for Specialty Products, which provides bio-tech ventures and pharmaceutical companies in Japan and abroad with the services required by them in the entire process, from product R&D through manufacturing to distribution.
We aim to realize this full-line service by taking on a range of services including: support for pharmaceutical development through investment in bio-tech ventures; secondary packaging at the Haneda Packaging Center established within the same facility as the TBC DynaBASE logistics center; manufacturer logistics; wholesale logistics consisting of delivery and inventory management, which is an existing strength of ours; and last-mile delivery of pharmaceuticals to the patient’s home.
2. SALM Solution System
The Group has introduced the SALM Solution System, which combines state-of-the-art logistics functions with an electronically cooled, constant-temperature transport device (SALM TS and SALM FZ), to handle specialty pharmaceuticals that require strict temperature control and recording.
This device is capable of handling a wide range of temperatures: from -25°C to +4°C for the SALM FZ and +4°C to +37°C for the SALM TS. In addition, since the system can continuously record the internal temperature for more than one month, it can provide proof that the quality of specialty pharmaceuticals is fully guaranteed. The system is operated in accordance with the Guide to Good Distribution Practice (GDP) for Medicinal Products. This makes product returns and resales possible and helps mitigate the risk of having to dispose of expensive specialty pharmaceuticals. Furthermore, the electronic cooling system does not use ice packs or dry ice, so CO2 emissions during operation can also be reduced. By reducing waste and unnecessary transportation, we are achieving a reduction in environmental impact across the entire supply chain.
Initiatives for specialty pharmaceuticals
(Link to TOHO PHARMACEUTICAL)